These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 834284)

  • 1. Feedback loop or output pathway in striato-nigral fibres?
    Garcia-Munoz M; Nicolaou MN; Tulloch IF; Wright AK; Arguthnott GW
    Nature; 1977 Jan; 265(5592):363-5. PubMed ID: 834284
    [No Abstract]   [Full Text] [Related]  

  • 2. The striatonigral fibres and the feedback control of dopamine metabolism.
    Tulloch IF; Arbuthnott GW; Wright AK; Garcia-Munoz M; Nicolaou NM
    Psychol Med; 1978 Aug; 8(3):471-82. PubMed ID: 30106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine release in substantia nigra?
    Korf J; Zieleman M; Westerink BH
    Nature; 1976 Mar; 260(5548):257-8. PubMed ID: 1256566
    [No Abstract]   [Full Text] [Related]  

  • 4. Cobalt injections into the substantia nigra of the rat: effects on behavior and dopamine metabolism in the striatum.
    Shibuya M; Fariello R; Farley IJ; Price KS; Lloyd KG; Hornykiewicz O
    Exp Neurol; 1978 Feb; 58(3):486-99. PubMed ID: 620704
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of dopamine in the substantia nigra after antidromic activation.
    Korf J; Zieleman M; Westerink BH
    Brain Res; 1977 Jan; 120(1):184-7. PubMed ID: 832118
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential regulation of dopamine metabolism in solid fetal substantia nigra transplants and their terminals in the host striatum.
    Meloni R; Gale K
    Prog Brain Res; 1990; 82():467-71. PubMed ID: 2127112
    [No Abstract]   [Full Text] [Related]  

  • 7. Bilateral dopamine metabolism in the striatum after unilateral application of tetrodotoxine in the midbrain of the rat.
    Korf J; Postema F
    Brain Res; 1980 Apr; 187(1):251-5. PubMed ID: 7357473
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased dopamine metabolism in rat striatum after infusions of substance P into the substantia nigra.
    Waldmeier PC; Kam R; Stöcklin K
    Brain Res; 1978 Dec; 159(1):223-7. PubMed ID: 728796
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen.
    Santiago M; Machado A; Cano J
    Br J Pharmacol; 1993 Jul; 109(3):814-8. PubMed ID: 7689406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatodendritic release of endogenous dopamine: in vivo dialysis in the A10 dopamine region.
    Kalivas PW; Bourdelais A; Abhold R; Abbott L
    Neurosci Lett; 1989 May; 100(1-3):215-20. PubMed ID: 2761771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the striato-nigral pathway responsible for 'feed-back' control of dopamine release [proceedings]?
    Arbuthnott GW; Garcia-Munoz M; Nicolaou NM; Tulloch IF; Wright AK
    Br J Pharmacol; 1976 Oct; 58(2):272P. PubMed ID: 974393
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of nigro-striatal dopaminergic neurotransmission in the rat.
    Dray A; Fowler LJ; Oakley NR; Simmonds MA; Tanner T
    Neuropharmacology; 1977; 16(7-8):511-8. PubMed ID: 199852
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
    Santiago M; Rollema H; de Vries JB; Westerink BH
    Brain Res; 1991 Jan; 538(2):226-30. PubMed ID: 1707325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal cord dopaminergic neurons: evidence for an uncrossed nigrospinal pathway.
    Commissiong JW; Gentleman S; Neff NH
    Neuropharmacology; 1979 Jun; 18(6):565-8. PubMed ID: 481709
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T; Knott P; Kaufmann H; Yahr M
    Adv Neurol; 1990; 53():75-81. PubMed ID: 2173378
    [No Abstract]   [Full Text] [Related]  

  • 16. Gamma-hydroxybutyrate: a role in the regulation of central dopaminergic neurons?
    Roth RH; Doherty JD; Walters JR
    Brain Res; 1980 May; 189(2):556-60. PubMed ID: 7370791
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of a high affinity transport system for dopamine in the median eminence and posterior pituitary.
    Demarest KT; Moore KE
    Brain Res; 1979 Aug; 171(3):545-51. PubMed ID: 476488
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of pyrethroids on dopamine and its metabolites in nigrostriatum of male rats].
    Liu GP; Shi N; Liang JH; Chen L
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Oct; 22(5):368-70. PubMed ID: 15555315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the nigrostriatal dopaminergic pathway by injection of cholera enterotoxin into the substantia nigra.
    Quenzer LF; Galli CL; Neff NH
    Science; 1977 Jan; 195(4273):78-80. PubMed ID: 831258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic development of prenatal ventral mesencephalon and striatum in organotypic co-cultures.
    Lyng GD; Snyder-Keller A; Seegal RF
    Brain Res; 2007 Feb; 1133(1):1-9. PubMed ID: 17196555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.